| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Jul 1, 2026 | Sell(S) | 38K | $17.00 | $643K | 9.2M |
| Jun 30, 2026 | Sell(S) | 25K | $17.13 | $429K | 9.2M |
| Jun 29, 2026 | Sell(S) | 274K | $17.23 | $4.7M | 9.2M |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001877589-26-000001) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Theravance Biopharma, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.